novel transcript, sense intronic to RP5-972B16.2 (ENSG00000306237)

This entity is described as a **novel transcript** located in the *sense orientation within the intron* of the gene locus RP5-972B16.2, according to the Ensembl gene annotation with identifier ENSG00000306237. It is not currently recognized as a protein-coding gene, characterized functional RNA, or any established therapeutic target class (such as receptor, enzyme, transporter, or transcription factor). Such entries are often the result of high-throughput transcriptome sequencing artifacts, automated annotation, or may represent poorly characterized or non-functional transcripts. There is no evidence supporting a biological role, disease association, or interaction with any drugs. Given the lack of characterization, it is not considered a valid therapeutic target, and its presence in target lists is likely erroneous. There is no indication in the literature or recognized databases that this is a protein, enzyme, receptor, clinically actionable target, or relevant biomarker. Summary: ENSG00000306237 is not an established molecular target (for drug development or biology). Its annotation suggests an uncharacterized, likely non-functional transcript without evidence for therapeutic, biomarker, or biological significance. It should not be considered a validated molecular target. If this entry appears in a list of drug targets, it is likely due to annotation error or insufficient curation.

Other names

sense intronic transcript RP5-972B16.2ENSG00000306237